Clinical Trial Update: PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update of PIPAC nab-paclitaxel for peritoneal carcinomatosis in stomach, pancreas, breast, and ovarian cancers with completed status and results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Peritoneal Carcinomatosis
• Stomach Cancer

Drugs mentioned

• PIPAC Nab-paclitaxel (nab-paclitaxel)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Peritoneal Carcinomatosis, Ovarian Cancer Stage IIIB | Phase 1 | Status: COMPLETED | Results posted: 2023-11-07